IPA questions FAERS data interpretation in the Ohio State University study
Express Pharma
MARCH 12, 2025
On the pricing of generics, IPA stated, While generics are priced lower than the corresponding brands, it is unfair and unacceptable to link quality with cost. It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing.
66 
Let's personalize your content